Endothelial progenitor cells: The promise of vascular stem cells for plastic surgery

Plastic and Reconstructive Surgery

Volumn 111, Issue 2, 2003, Pages 846-854

  Tepper, Oren M ^a   Galiano, Robert D ^a   Kalka, Christoph ^a   Gurtner, Geoffrey C ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; SOMATOMEDIN C; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL MODEL; ARTICLE; BLOOD VESSEL GRAFT; CELL DIFFERENTIATION; CELL MIGRATION; EMBRYO; ENDOTHELIUM CELL; GENE TRANSFER; HUMAN; HUMAN CELL; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; RABBIT; STEM CELL; TISSUE ENGINEERING; TISSUE EXPANSION; TISSUE FLAP; WOUND HEALING;

ANIMALS; ENDOTHELIUM, VASCULAR; GRAFT SURVIVAL; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; STEM CELL TRANSPLANTATION; SURGERY, PLASTIC; SURGICAL FLAPS; TISSUE ENGINEERING; TISSUE EXPANSION; WOUND HEALING;

EID: 0037316829     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PRS.0000039576.63523.08     Document Type: Article

References (92)

1. Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., et al. Embryonic stem cell lines derived from human blastocysts. Science 282: 1145, 1998.
2. Shamblott, M.J., Axelman, J., Wang, S., et al. Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc. Natl. Acad. Sci. U.S.A. 95: 13726, 1998.
3. Weissman, I. L., and Baltimore, D. Disappearing stem cells, disappearing science. Science 292: 601, 2001.
4. Vogel, G. Stem cell policy: Can adult stem cells suffice? Science 292: 1820, 2001.
5. Fuchs, E., and Segre, J.A. Stem cells: A new lease on life. Cell 100: 143, 2000.
6. Toma, J. G., Akhavan, M., Fernandes, K. J., et al. Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat. Cell Biol. 3: 778, 2001.
7. Pittenger, M. F., Mackay, A. M., Beck, S. C., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284: 143, 1999.
8. Clarke, D. L., Johansson, C. B., Wilbertz, J., et al. Generalized potential of adult neural stem cells. Science 288: 1660, 2000.
9. Gage, F. H. Mammalian neural stem cells. Science 287: 1433, 2000.
10. To, L. B., Haylock, D. N., Simmons, P. J., and Juttner, C. A. The biology and clinical uses of blood stem cells. Blood 89: 2233, 1997.
11. Jones, P. H., and Watt, F. M. Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression. Cell 73: 713, 1993.
12. Asahara, T., Murohara, T., Sullivan, A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964, 1997.
13. Flax, J. D., Aurora, S., Yang, C., et al. Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes. Nat. Biotechnol. 16: 1033, 1998.
14. Kalka, C., Masuda, H., Takahashi, T., et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl. Acad. Sci. U.S.A. 97: 3422, 2000.
15. Gluckman, E., Rocha, V., Boyer-Chammard, A., et al. Outcome of cord-blood transplantation from related and unrelated donors: Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N. Engl. J. Med. 337: 373, 1997.
16. Cairo, M. S., and Wagner, J. E. Placental and/or umbilical cord blood: An alternative source of hematopoietic stem cells for transplantation. Blood 90: 4665, 1997.
17. Donski, P. K., Carwell, G. R., and Sharzer, L. A. Growth in revascularized bone grafts in young puppies. Plast. Reconstr. Surg. 64: 239, 1979.
18. Cutting, C. B., McCarthy, J. G., and Berenstein, A. Blood supply of the upper craniofacial skeleton: The search for composite calvarial bone flaps. Plast. Reconstr. Surg. 74: 603, 1984.
19. Rowe, N. M., Mehrara, B. J., Luchs, J. S., et al. Angiogenesis during mandibular distraction osteogenesis. Ann. Plast. Surg. 42: 470, 1999.
20. Tonnesen, M. G., Feng, X., and Clark, R. A. Angiogenesis in wound healing. J. Invest. Dermatol. Symp. Proc. 5: 40, 2000.
21. Burget, G. C., and Menick, F. J. Nasal support and lining: The marriage of beauty and blood supply. Plast. Reconstr. Surg. 84: 189, 1989.
22. Dhar, S. C., and Taylor, G. I. The delay phenomenon: The story unfolds. Plast. Reconstr. Surg. 104: 2079, 1999.
23. Risau, W., Sariola, H., Zerwes, H. G., et al. Vasculogenesis and angiogenesis in embryonic-stem-cell-derived embryoid bodies. Development 102: 471, 1988.
24. Folkman, J. Tumor angiogenesis: Therapeutic implications. N. Engl. J. Med. 285: 1182, 1971.
25. Murohara, T., Horowitz, J. R., Silver, M., et al. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation 97: 99, 1998.
26. Fukumura, D., Yuan, F., Endo, M., and Jain, R. K. Role of nitric oxide in tumor microcirculation: Blood flow, vascular permeability, and leukocyte-endothelial interactions. Am. J. Pathol. 150: 713, 1997.
27. Thurston, G., Rudge, J. S., Ioffe, E., et al. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat. Med. 6: 460, 2000.
28. Maisonpierre, P. C., Suri, C., Jones, P. F., et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277: 55, 1997.
29. Ausprunk, D. H., and Folkman, J. Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc. Res. 14: 53, 1977.
30. Conway, E. M., Collen, D., and Carmeliet, P. Molecular mechanisms of blood vessel growth. Cardiovasc. Res. 49: 507, 2001.
31. Shing, Y., Folkman, J., Sullivan, R., Butterfield, C., Murray, J., and Klagsbrun, M. Heparin affinity: Purification of a tumor-derived capillary endothelial cell growth factor. Science 223: 1296, 1984.
32. Ferrara, N., and Henzel, W. J. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun. 161: 851, 1989.
33. Keck, P. J., Hauser, S. D., Krivi, G., et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246: 1309, 1989.
34. Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., and Holash, J. Vascular-specific growth factors and blood vessel formation. Nature 407: 242, 2000.
35. Takeshita, S., Zheng, L. P., Brogi, E., et al. Therapeutic angiogenesis: A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J. Clin. Invest. 93: 662, 1994.
36. Losordo, D. W., Vale, P. R., Symes, J. F., et al. Gene therapy for myocardial angiogenesis: Initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 98: 2800, 1998.
37. Isner, J. M. Angiogenesis, a "breakthrough" technology in cardiovascular medicine. J. Invasive Cardiol. 12 (Suppl. A): 14A, 2000.
38. Isner, J. M., and Asahara, T. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J. Clin. Invest. 103: 1231, 1999.
39. Isner, J. M. St. Elizabeth's Medical Center, Brighton, Mass., personal communication, 2001.
40. Edelberg, J. M., Tang, L., Hattori, K., Lyden, D., and Rafii, S. Young adult bone marrow-derived endothelial precursor cells restore aging-impaired cardiac angiogenic function. Circ. Res. 90: E89, 2002.
41. Asahara, T., Masuda, H., Takahashi, T., et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 85: 221, 1999.
42. Iwaguro, H., Yamaguchi, J., Kalka, C., et al. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 105: 732, 2002.
43. Shi, Q., Rafii, S., Wu, M. H., et al. Evidence for circulating bone marrow-derived endothelial cells. Blood 92: 362, 1998.
44. Lin, Y., Weisdorf, D. J., Solovey, A., and Hebbel, R. P. Origins of circulating endothelial cells and endothelial outgrowth from blood. J. Clin. Invest. 105: 71, 2000.
45. Crosby, J. R., Kaminski, W. E., Schatteman, G., et al. Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation. Circ. Res. 87: 728, 2000.
46. Murayama, T., Tepper, O. M., Silver, M., et al. Determination of bone marrow-derived endothelial progenitor cell significance to angiogenic growth factor-induced neovascularization in vivo. Exp. Hematol. 30: 967, 2002.
47. Takahashi, T., Kalka, C., Masuda, H., et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 5: 434, 1999.
48. Shintani, S., Murohara, T., Ikeda, H., et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 103: 2776, 2001.
49. + endothelial precursor cells. Circ. Res. 88: 167, 2001.
50. Kalka, C., Masuda, H., Takahashi, T., et al. Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects. Circ. Res. 86: 1198, 2000.
51. Kalka, C., Tehrani, H., Laudenberg, B., et al. VEGF gene transfer mobilizes endothelial progenitor cells in patients with inoperable coronary disease. Ann. Thorac. Surg. 70: 829, 2000.
52. Galiano, R. D., Tepper, O. M., Callaghan, M., Pelo, C. R., Levine, J. P., and Gurtner, G. C. Topical VEGF accelerates diabetic wounds and mobilizes endothelial progenitor cells. 47th Annual Plastic Surgery Research Council Meeting, Boston, April 17-20, 2002 (Oral presentation).
53. Vasa, M., Fichtlscherer, S., Adler, K., et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 103: 2885, 2001.
54. Walter, D. H., Rittig, K., Bahlmann, F. H., et al. Statin therapy accelerates reendothelialization: A novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 105: 3017, 2002.
55. Kawamoto, A., Gwon, H. C., Iwaguro, H., et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103: 634, 2001.
56. Murohara, T., Ikeda, H., Duan, J., et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J. Clin. Invest. 105:1527, 2000.
57. Schatteman, G. C., Hanlon, H. D., Jiao, C., Dodds, S. G., and Christy, B. A. Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. J. Clin. Invest. 106: 571, 2000.
58. + cell counts decrease hematologic toxicity of autologous peripheral blood progenitor cell transplantation. Blood 91: 3148, 1998.
59. Tepper, O. M., and Mehrara, B. J. Gene therapy in plastic surgery. Plast. Reconstr. Surg. 109: 716, 2002.
60. Taub, P. J., Silver, L., and Weinberg, H. Plastic surgical perspectives on vascular endothelial growth factor as gene therapy for angiogenesis. Plast. Reconstr. Surg. 105: 1034, 2000.
61. Taub, P. J., Marmur, J. D., Zhang, W. X., et al. Locally administered vascular endothelial growth factor cDNA increases survival of ischemic experimental skin flaps. Plast. Reconstr. Surg. 102: 2033, 1998.
62. Yla-Herttuala, S., and Martin, J. F. Cardiovascular gene therapy. Lancet 355: 213, 2000.
63. Padubidri, A., and Browne, E., Jr. Effect of vascular endothelial growth factor (VEGF) on survival of random extension of axial pattern skin flaps in the rat. Ann. Plast. Surg. 37: 604, 1996.
64. Park, S., Tepper, O. M., Galiano, R. D., et al. Endothelial progenitor cells selectively home to sites of ischemia and inflammation and increase neovascularization. 47th Annual Plastic Surgery Research Council Meeting, Boston, April 17-20, 2002 (Oral presentation).
65. American Diabetes Association Consensus Development Conference on Diabetic Foot Wound Care: 7-8 April 1999, Boston, Massachusetts: American Diabetes Association. Diabetes Care 22: 1354, 1999.
66. Parkhouse, N., and Le Quesne, P. M. Impaired neurogenic vascular response in patients with diabetes and neuropathic foot lesions. N. Engl. J. Med. 318: 1306, 1988.
67. Boulton, A. J. The pathogenesis of diabetic foot problems: An overview. Diabetes Med. 13 (Suppl. 1): S12, 1996.
68. Tepper, O. M., Galiano, R. D., Capla, J., et al. Endothelial progenitor cells isolated from human type-II diabetics exhibit impaired adhesion, proliferation, and incorporation into vascular structures. Circulation 106: 2781, 2002.
69. Llevadot, J., Murasawa, S., Kureishi, Y., et al. HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J. Clin. Invest. 108: 399, 2001.
70. Langer, R., and Vacanti, J. P. Tissue engineering. Science 260: 920, 1993.
71. Fuchs, J. R., Nasseri, B. A., and Vacanti, J. P. Tissue engineering: A 21st century solution to surgical reconstruction. Ann. Thorac. Surg. 72: 577, 2001.
72. Nakahara, H., Goldberg, V. M., and Caplan, A. I. Culture-expanded periosteal-derived cells exhibit osteochondrogenic potential in porous calcium phosphate ceramics in vivo. Clin. Orthop. 276: 291, 1992.
73. Cima, L. G., Vacanti, J. P., Vacanti, C., Ingber, D., Mooney, D., and Langer, R. Tissue engineering by cell transplantation using degradable polymer substrates. J. Biomech. Eng. 113: 143, 1991.
74. Cao, Y., Vacanti, J. P., Ma, X., et al. Generation of neotendon using synthetic polymers seeded with tenocytes. Transplant. Proc. 26: 3390, 1994.
75. Schreiber, R. E., Ilten-Kirby, B. M., Dunkelman, N. S., et al. Repair of osteochondral defects with allogeneic tissue engineered cartilage implants. Clin. Orthop. 367 (Suppl.): S382, 1999.
76. Huang, D., Chang, T. R., Aggarwal, A., Lee, R. C., and Ehrlich, H. P. Mechanisms and dynamics of mechanical strengthening in ligament-equivalent fibroblast-populated collagen matrices. Ann. Biomed. Eng. 21: 289, 1993.
77. Naughton, G., Mansbridge, J., and Gentzkow, G. A metabolically active human dermal replacement for the treatment of diabetic foot ulcers. Artif. Organs 21: 1203, 1997.
78. Noordenbos, J., Dore, C., and Hansbrough, J. F. Safety and efficacy of TransCyte for the treatment of partial-thickness burns. J. Burn Care Rehabil. 20: 275, 1999.
79. Folkman, J. The role of angiogenesis in tumor growth. Semin. Cancer Biol. 3: 65, 1992.
80. Al-Khaldi, A., Eliopoulos, N., Lachapelle, K., and Galipeau, J. VEGF-dependent angiogenic response induced by ex vivo cultured marrow stromal cells. American Heart Association Scientific Session, Anaheim, Calif., November 11-14, 2001 (Poster presentation).
81. Chung, S., Hazen, A., Levine, J. P., et al. Vascularized acellular dermal matrix island flaps for the repair of abdominal muscle defects. Plast. Reconstr. Surg. 111: 225, 2003.
82. Ratcliffe, A. Tissue engineering of vascular grafts. Matrix Biol. 19: 353, 2000.
83. Huynh, T., Abraham, G., Murray, J., Brockbank, K., Hagen, P. O., and Sullivan, S. Remodeling of an acellular collagen graft into a physiologically responsive neovessel. Nat. Biotechnol. 17: 1083, 1999.
84. Schmidt, C. E., and Baier, J. M. Acellular vascular tissues: Natural biomaterials for tissue repair and tissue engineering. Biomaterials 21: 2215, 2000.
85. Schmidt, S. P., Hunter, T. J., Sharp, W. V., Malindzak, G. S., and Evancho, M. M. Endothelial cell-seeded four-millimeter Dacron vascular grafts: Effects of blood flow manipulation through the grafts. J. Vasc. Surg. 1: 434, 1984.
86. Jarrell, B. E., Williams, S. K., Stokes, G., et al. Use of freshly isolated capillary endothelial cells for the immediate establishment of a monolayer on a vascular graft at surgery. Surgery 100: 392, 1986.
87. Deutsch, M., Meinhart, J., Fischlein, T., Preiss, P., and Zilla, P. Clinical autologous in vitro endothelialization of infrainguinal ePTFE grafts in 100 patients: A 9-year experience. Surgery 126: 847, 1999.
88. Weinberg, C. B., and Bell, E. A blood vessel model constructed from collagen and cultured vascular cells. Science 231: 397, 1986.
89. L'Heureux, N., Paquet, S., Labbe, R., Germain, L., and Auger, F. A. A completely biological tissue-engineered human blood vessel. F.A.S.E.B.J. 12: 47, 1998.
90. Kaushal, S., Amiel, G. E., Guleserian, K. J., et al. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat. Med. 7: 1035, 2001.
91. Tkebuchava, T., Pola, R., Murayama, T., et al. Circulating endothelial progenitor cells provide neo-endothelium for tissue-engineered bio-arterial conduits. American Heart Association Scientific Session, Anaheim, Calif., November 11-14, 2001 (Poster presentation).
92. Tepper, O., Murayama, T., Silver, M., et al. Bone marrow-derived endothelial progenitor cells contribute to recanalization and resolution of an existing thrombus. Arteriosclerosis, Thrombosis, and Vascular Biology Conference, Salt Lake City, Utah, April 6-8, 2002 (Oral presentation).